Recent Quarter Total Invested
$641.42 M
Recent Quarter Institutional Ownership Percentage
114.52%
Total Invested of Last Quarter
$407.38 M
Ownership Percentage of Last Quarter
75.13%
UroGen Pharma Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 08/14/2024 | 3.56 M | $59.69 M | 9.21% | 10.66% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 3.30 M | $55.37 M | 153.85% | 9.89% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 3.08 M | $51.74 M | 0.00% | 9.24% |
| GREAT POINT PARTNERS LLC | 08/14/2024 | 2.91 M | $48.77 M | 10.90% | 8.71% |
| POINT72 ASSET MANAGEMENT, L.P. | 09/16/2024 | 2.45 M | $41.10 M | 120.25% | 7.34% |
| MENORA MIVTACHIM HOLDINGS LTD. | 08/13/2024 | 2.30 M | $38.64 M | 0.00% | 6.90% |
| BLACKROCK INC. | 08/13/2024 | 2.19 M | $36.81 M | 27.79% | 6.57% |
| COWEN AND COMPANY, LLC | 08/07/2024 | 2.10 M | $35.23 M | 29.07% | 6.29% |
| MORGAN STANLEY | 10/17/2024 | 1.84 M | $30.85 M | 370.80% | 5.51% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2024 | 1.65 M | $27.69 M | 100.00% | 4.94% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/14/2024 | 1.32 M | $22.15 M | 100.00% | 3.95% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 1.16 M | $19.48 M | 2,671.97% | 3.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/14/2024 | 1.10 M | $18.49 M | 116.68% | 3.30% |
| JEFFERIES FINANCIAL GROUP INC. | 08/13/2024 | 965,000 | $16.19 M | 14.88% | 2.89% |
| STATE STREET CORP | 08/14/2024 | 726,676 | $12.19 M | 35.32% | 2.18% |
| MIGDAL INSURANCE & FINANCIAL HOLDINGS LTD. | 07/29/2024 | 686,472 | $11.52 M | 0.00% | 2.06% |
| WILDCAT CAPITAL MANAGEMENT, LLC | 08/14/2024 | 495,606 | $8.32 M | 0.00% | 1.48% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2024 | 469,000 | $7.87 M | 100.00% | 1.41% |
| HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD. | 07/22/2024 | 463,565 | $7.78 M | -31.17% | 1.39% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 421,389 | $7.07 M | 30.08% | 1.26% |
| OPALEYE MANAGEMENT INC. | 08/14/2024 | 412,000 | $6.91 M | 52.59% | 1.23% |
| WOODLINE PARTNERS LP | 08/14/2024 | 303,740 | $5.10 M | 100.00% | 0.91% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2024 | 274,465 | $4.61 M | 49.02% | 0.82% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 263,606 | $4.42 M | 131.51% | 0.79% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 248,399 | $4.17 M | 138.62% | 0.74% |
| VANGUARD GROUP INC | 08/13/2024 | 223,982 | $3.76 M | 14.88% | 0.67% |
| NORTHERN TRUST CORP | 08/14/2024 | 217,362 | $3.65 M | -6.51% | 0.65% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 215,841 | $3.62 M | 1.68% | 0.65% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 173,966 | $2.92 M | 596.67% | 0.52% |
| LAURION CAPITAL MANAGEMENT LP | 08/14/2024 | 160,600 | $2.69 M | -35.91% | 0.48% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 156,078 | $2.62 M | 14.14% | 0.47% |
| ARK INVESTMENT MANAGEMENT LLC | 07/26/2024 | 151,781 | $2.55 M | 3.73% | 0.45% |
| ATOM INVESTORS LP | 08/14/2024 | 144,780 | $2.43 M | 190.78% | 0.43% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 100,422 | $1.69 M | 24.75% | 0.30% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2024 | 100,000 | $1.68 M | 100.00% | 0.30% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 96,619 | $1.62 M | 41.63% | 0.29% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 96,345 | $1.62 M | 251.48% | 0.29% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 92,957 | $1.56 M | 11.43% | 0.28% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 82,917 | $1.39 M | 31.87% | 0.25% |
| DE LISLE PARTNERS LLP | 08/09/2024 | 81,510 | $1.37 M | 5.73% | 0.24% |
| TREXQUANT INVESTMENT LP | 08/13/2024 | 80,709 | $1.35 M | 100.00% | 0.24% |
| OAK RIDGE INVESTMENTS LLC | 10/28/2024 | 79,929 | $1.34 M | 30.59% | 0.24% |
| ANNANDALE CAPITAL, LLC | 08/15/2024 | 75,552 | $1.27 M | -7.36% | 0.23% |
| CITADEL ADVISORS LLC | 08/14/2024 | 74,362 | $1.25 M | 3.55% | 0.22% |
| CAPTION MANAGEMENT, LLC | 08/14/2024 | 73,700 | $1.24 M | 100.00% | 0.22% |
| RICE HALL JAMES & ASSOCIATES, LLC | 08/07/2024 | 72,787 | $1.22 M | 3.38% | 0.22% |
| CAPTION MANAGEMENT, LLC | 08/14/2024 | 68,000 | $1.14 M | 100.00% | 0.20% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 66,086 | $1.11 M | 24.54% | 0.20% |
| JANE STREET GROUP, LLC | 08/15/2024 | 60,316 | $1.01 M | 169.06% | 0.18% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 59,500 | $998,410 | 142.86% | 0.18% |
UroGen Pharma Ltd.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of URGN shares?
During the previous two years, 59 institutional investors and hedge funds held shares of UroGen Pharma Ltd.. The most heavily invested institutionals were:
Lindbrook Capital, LLC: 0
Allspring Global Investments Holdings, LLC: 0
Alyeska Investment Group, L.P.: 0
Walleye Capital LLC: 0
TORONTO DOMINION BANK: 0
Atom Investors LP: 0
-
What percentage of UroGen Pharma Ltd. stock is owned by institutional investors?
114.52% of UroGen Pharma Ltd. stock is owned by institutional investors.
-
How much institutional buying is happening at URGN ?
Institutional investors have bought a total of 11.33 M shares in the last 24 months. This purchase volume represents approximately $126.76 M in transactions.